Veracyte Inc. (VCYT) had a good day on the market for Thursday December 05 as shares jumped 5.8% to close at $29.99. About 902,026 shares traded hands on 8,439 trades for the day, compared with an average daily volume of n/a shares out of a total float of 48.84 million. After opening the trading day at $28.50, shares of Veracyte Inc. stayed within a range of $30.03 to $28.37.
With today’s gains, Veracyte Inc. now has a market cap of $1.46 billion. Shares of Veracyte Inc. have been trading within a range of $31.18 and $10.72 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against the diseases such as thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. The firm’s product portfolio consists of products such as Afirma analysis, Percepta, Envisia and others. The company derives its revenues from the Sale of Afirma analysis product.
Veracyte Inc. is based out of South San Francisco, CA and has some 270 employees. Its CEO is Bonnie H. Anderson.
Veracyte Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
